Toulsie Ramtohul

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

ASO Visual Abstract: Association Between Axillary Surgical Management and Survival in Patients with de novo Metastatic Breast Cancer.

ASO Visual Abstract: Association Between Axillary Surgical Management and Survival in Patients with de novo Metastatic Breast Cancer.

Journal: Annals of surgical oncology

Published: June 29, 2026

Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence.

Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence.

Journal: Breast cancer research and treatment

Published: April 27, 2026

Breast cryoablation for small, low-risk breast cancers: Current evidence, practical integration, and future directions.

Breast cryoablation for small, low-risk breast cancers: Current evidence, practical integration, and future directions.

Journal: Diagnostic and interventional imaging

Published: April 20, 2026

Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer.

Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer.

Journal: Annals of surgical oncology

Published: April 08, 2026

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.

Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp.

Journal: Diagnostic and interventional imaging

Published: December 09, 2025

Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer.

Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer.

Journal: Cell reports. Medicine

Published: November 24, 2025

Breast MR imaging without gadolinium-based contrast agents: A visionary goal or scientific mirage?

Breast MR imaging without gadolinium-based contrast agents: A visionary goal or scientific mirage?

Journal: Diagnostic and interventional imaging

Published: November 12, 2025

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

Letter Re: "Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations".

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 27, 2025

Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy.

Journal: Radiology

Published: July 01, 2025

Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune Myocarditis.

Cardiac Outcomes Following Adjuvant Radiation Therapy in Triple-Negative Breast Cancer Patients With Prior Autoimmune Myocarditis.

Journal: International journal of radiation oncology, biology, physics

Published: January 02, 2025

Clinico-pathological factors predicting pathological response in early triple-negative breast cancer.

Clinico-pathological factors predicting pathological response in early triple-negative breast cancer.

Journal: NPJ breast cancer

Published: November 06, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026